• Search
  • Contact Us
  • Blogs
  • Healthcare Professionals
    • Blogs
      • Expand OAB Care
      • Sterile Endoscopy
    • Specialties
      • Urology
      • Endourology
      • Gynecology
      • Bariatric Medicine
      • Critical Care
      • Gastroenterology
      • Infection Prevention
      • Otolaryngology
      • Pulmonology
      • Senior Living
    • Products
      • PrimeSight
        • Clinical Data
        • Flexible Endoscopes
        • Rigid Endoscopes
        • Video System
        • Light Sources
        • Accessories
      • EndoSheath
        • Clinical Data
      • Urgent PC
        • Clinical Data
      • Macroplastique
        • Clinical Data
    • Reimbursement
      • Urgent PC
        • Coverage Finder
        • Prior Auth
        • Appeals
      • Macroplastique
        • Prior Auth
        • Appeals
      • Endoscopy
    • Upcoming Meetings
    • Resource Center
  • Patients
    • Find a Provider
    • Conditions
      • Overactive Bladder
      • Stress Urinary Incontinence
    • Endoscope Safety
    • Products
      • PrimeSight
      • Macroplastique
        • Stories
      • Urgent PC
        • Stories
    • Resource Center
    • MyPTNS
  • Customer Care
    • Product Ordering
      • Ordering Questions
      • New Account Form
      • Service Plans
      • Terms and Conditions
    • Repair and Support
      • Technical Support Questions
      • Returns and Feedback
        • Incident Report
      • Product Instructions
    • Contact Customer Care
  • About Us
    • Locations
    • History
    • Affiliations
    • Careers
      • Available Positions
Cogentix Medical
Menu

Percutaneous tibial nerve stimulation (PTNS): Results at long-term follow-up.

Cappellano, F., et al. (2006). Poster, SIUD National Congress, Italy.

OBJECTIVE:  To investigate whether PTNS results are maintained for months or years after treatment and the need for chronic PTNS therapy.

MATERIALS AND METHODS: Retrospective analysis of 256 patients treated with PTNS for overactive bladder (OAB) or non-obstructive urinary retention (NOUR) who had previously been treated with conventional treatments (drugs, behavioral therapy, rehabilitation protocols) with unsatisfactory results. OAB responders were considered to be those with >50% reduction in micturitions episodes.  NOUR responders were considered to be those with a >50% reduction of the total catheterized volume/day.  Responders were treated with a tapering protocol of PTNS every 2 weeks, every 3 weeks and so on.  Some patients received home-based treatment with transcutaneous tibial nerve stimulation.  Results were obtained using voiding diaries and quality of life questionnaires.

RESULTS: 112 responders were treated by means of a tapering protocol of stimulations or home-based treatment (33). Mean follow-up was 35 months (range 2-72 months).  135 of 145 patients requested periodic stimulations and showed a worsening of their clinical situation after discontinuation of the treatment. 10 patients showed stability of obtained results some months after discontinuation of treatment. 15 patients (10%) were not classifiable as responders at maximum follow-up.  Differences immediately after PTNS therapy and at maximum follow-up were not statistically different for mean catheterized vol/day (ml) of 120 ml compared to 85 ml; number of catheterizations/day of 1.8 compared to 1.5; number of micturitions/day of 7 compared to 7; number of incontinence episodes/day of 1 compared to 0.8; I-QoL of 95 compared to 95; and total responders at 100% compared to 90%.

CONCLUSION: PTNS is an effective treatment for OAB and NOUR with stable results at 3-year mean follow-up. Patients need a periodic stimulation to maintain the obtained results.

Source: Uroplasty summary of original abstract

  • Twitter
  • Facebook
  • YouTube
  • Contact Us
  • Terms of Use
  • Privacy Center
© 2021 Cogentix Medical. Some Cogentix Medical products may not be available in certain regions.

What can we help you with?

  • Find A Provider
  • Customer Care
  • Expert Information